Alcon Acquires LumiThera, Developer of FDA-Authorized Valeda Vision Device for Dry AMD

Alcon has acquired LumiThera, the developer of the FDA-authorized Valeda Light Delivery System, a device that improves vision in dry age-related macular degeneration patients using photobiomodulation. LumiThera will spin off its diagnostic business into a new company named OpZira, Inc.

No comments yet.